Rong Hui Finance Shenzhen Tong details will come out actively layout of investment opportunities 小坂めぐる

Rong Hui Finance: Shenzhen Tong details will come out actively layout of investment opportunities in Sina Finance App: Live on-line blogger to tutor Sina Hong Kong APP: real time market exclusive reference stocks also worth the investment? What’s the problem? Where is the future of the way out? Sina launched the "Hong Kong Hong Kong stocks as well as unattractive" discussion, with a rational and constructive attitude, welcome attention to Hong Kong stocks, concern of the capital market, Hong Kong stocks together for suggestions, seek the Hong Kong stock market tomorrow. Please to hkstock_biz@sina. The Hong Kong Stock Exchange (00388.HK) CEO Li Xiaojia said that the Shenzhen Tong currently is in the final stages of the preparatory work, the next one or two days, and the securities operation details of coordination, believe in early November have announced. Since the deep through on August officially announced, has been the focus of Hong Kong stocks. The Shenzhen Hong Kong through measures help interoperability, and promote the development of the two markets investment climate. At the same time, with the China Insurance Regulatory Commission to allow venture capital to participate in the Shanghai and Hong Kong through the pilot, the medium-term is expected to continue to boost the enthusiasm of the funds south. The Shenzhen investment opportunities after the opening, Credit Suisse believes that there are two major categories, the South Fund may pay attention to than the A shares discount large Hong Kong stocks, funds may pay attention to the North A shares unique investment subject shares. The main Credit Suisse in intelligent mobile phone equipment industry selection of Shenzhen and Hong Kong through stocks, because the industry this year an increase of double-digit growth in demand, is expected to continue until the first half of next year, because the mainland mobile phone brand will continue to acoustics, camera, shell and fingerprint upgrade, more optimistic about the optical (02382.HK), AAC (02018.HK), access (00698.HK) and Chinese software (00354.HK). Strong performance of the sound, the second quarter revenue and earnings growth in the quarter by 19%, gross margin increased to 41.7%, the market is generally expected to maintain strong in the third quarter. However, the recent share price significantly compressed AAC, Credit Suisse believes that market worries the wireless RF and mechanical parts business, and as close to November announced third quarter results, the share price performance will be improved to the target price of 94.9 yuan. At the beginning of September showed AAC head and shoulders pattern, analysts suggest that when the level of 70 yuan to absorb. On the other hand, in the Shenzhen AH discount shares, individual quality stocks still bullish, which may pay attention to Rachel medicine (01513.HK) yesterday, the stock rose 3.4%, a 23.6% discount to its H shares than A shares. Livzon pharmaceutical interim results, turnover of 3 billion 780 million yuan, up 21%, profit 410 million yuan, up 20%. Gold refers to the company’s performance in line with expectations, the prescription drug business development maintained a strong momentum, injection revenue grew 15.2% to 820 million yuan, exceeding market expectations, to maintain a "buy" rating, target price of 54 yuan. Earlier, the central government launched the healthy China 2030 plan, under the national policy support, the entire pharmaceutical sector prospects look high. In addition, Livzon pharmaceutical has recently been partners Group Holdings, reflecting the long-term investment value. The strategy, Livzon pharmaceutical shares yesterday with large turnover rose, is brewing on the broken top.相关的主题文章: